India, June 1 -- Aditxt, Inc. (ADTX), a biopharmaceutical company, announced that Amro Albanna, the Chief Executive Officer and Co-founder, has resigned and has appointed Jeffrey M. Busch as the interim Chief Executive Officer, effective May 31, 2026.
Busch brings experience as the founder, Chairman, and former Chief Executive Officer of Global Medical REIT, Inc., now Chiron Real Estate, Inc.
He succeeds the position, after serving as the CEO of Aditxt's CLIA-certified precision oncology diagnostics subsidiary Ignite Proteomics, LLC since March 2026.
ADTX is currently trading down 9.98% to $0.10.
For comments and feedback contact: editorial@rttnews.com
Published by HT Digital Content Services with permission from RTT News....